H

Hubei Jumpcan Pharmaceutical Co Ltd
SSE:600566

Watchlist Manager
Hubei Jumpcan Pharmaceutical Co Ltd
SSE:600566
Watchlist
Price: 26.9 CNY 0.04% Market Closed
Market Cap: 24.8B CNY

Intrinsic Value

The intrinsic value of one Hubei Jumpcan Pharmaceutical Co Ltd stock under the Base Case scenario is 38.1 CNY. Compared to the current market price of 26.9 CNY, Hubei Jumpcan Pharmaceutical Co Ltd is Undervalued by 29%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
38.1 CNY
Undervaluation 29%
Intrinsic Value
Price
H
Worst Case
Base Case
Best Case

Valuation History
Hubei Jumpcan Pharmaceutical Co Ltd

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Hubei Jumpcan Pharmaceutical Co Ltd
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for Hubei Jumpcan Pharmaceutical Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Hubei Jumpcan Pharmaceutical Co Ltd
SSE:600566
CN
Pharmaceuticals
Market Cap
24.8B CNY
IPO
Aug 22, 2001
CN
Pharmaceuticals
Market Cap
24.8B CNY
IPO
Aug 22, 2001
Price
ÂĄfalse
EPS
ÂĄfalse
Company Overview
Loading...
Business Segments
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Hubei Jumpcan Pharmaceutical Co Ltd
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Hubei Jumpcan Pharmaceutical Co Ltd

Current Assets 14.7B
Cash & Short-Term Investments 11.8B
Receivables 2.3B
Other Current Assets 596.6m
Non-Current Assets 3.8B
Long-Term Investments 470m
PP&E 2.8B
Intangibles 478m
Other Non-Current Assets 45.3m
Efficiency

Free Cash Flow Analysis
Hubei Jumpcan Pharmaceutical Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Hubei Jumpcan Pharmaceutical Co Ltd

Revenue
7.1B CNY
Cost of Revenue
-1.7B CNY
Gross Profit
5.5B CNY
Operating Expenses
-3.3B CNY
Operating Income
2.1B CNY
Other Expenses
16.6m CNY
Net Income
2.1B CNY
Fundamental Scores

Profitability Score
Profitability Due Diligence

Hubei Jumpcan Pharmaceutical Co Ltd's profitability score is 71/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROIC
Positive Free Cash Flow
Positive Gross Profit
Exceptional ROIC
71/100
Profitability
Score

Hubei Jumpcan Pharmaceutical Co Ltd's profitability score is 71/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Hubei Jumpcan Pharmaceutical Co Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
87/100
Solvency
Score

Hubei Jumpcan Pharmaceutical Co Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Hubei Jumpcan Pharmaceutical Co Ltd

Wall Street analysts forecast Hubei Jumpcan Pharmaceutical Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Hubei Jumpcan Pharmaceutical Co Ltd is 53.41 CNY with a low forecast of 52.88 CNY and a high forecast of 54.98 CNY.

Lowest
Price Target
52.88 CNY
97% Upside
Average
Price Target
53.41 CNY
99% Upside
Highest
Price Target
54.98 CNY
104% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Hubei Jumpcan Pharmaceutical Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
What is the Intrinsic Value of one Hubei Jumpcan Pharmaceutical Co Ltd stock?

The intrinsic value of one Hubei Jumpcan Pharmaceutical Co Ltd stock under the Base Case scenario is 38.1 CNY.

Is Hubei Jumpcan Pharmaceutical Co Ltd stock undervalued or overvalued?

Compared to the current market price of 26.9 CNY, Hubei Jumpcan Pharmaceutical Co Ltd is Undervalued by 29%.

Back to Top